Zhaoyong Zhang

发表

Two novel human coronavirus OC43 genotypes circulating in hospitalized children with pneumonia in China

Jincun Zhao, Jingxian Zhao, Yanqun Wang, 2021, Emerging microbes & infections.

Complete Genome Sequences of Five Human Coronavirus NL63 Strains Causing Respiratory Illness in Hospitalized Children in China

Fuchun Zhang, Jincun Zhao, Jingxian Zhao, 2020, Microbiology Resource Announcements.

Plasma cell-free RNA characteristics in COVID-19 patients

Junhua Li, Huanming Yang, Jian Wang, 2022, Genome research.

Advances in drug therapy for mitochondrial diseases.

Haishan Jiang, Zhaoyong Zhang, Lufei Zhang, 2020, Annals of translational medicine.

Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient

Xinwen Chen, Jincun Zhao, Yimin Li, 2020, Emerging microbes & infections.

Intranasal Lentiviral Vector-Mediated Antibody Delivery Confers Reduction of SARS-CoV-2 Infection in Elderly and Immunocompromised Mice

Jincun Zhao, S. Hyde, D. Gill, 2022, Frontiers in Immunology.

A pair of SARS-CoV-2 nucleocapsid protein monoclonal antibodies shows high specificity and sensitivity for diagnosis

Sa Li, Jincun Zhao, Mingjian Lu, 2022, Virologica Sinica.

Clinical Features of Familial Amyloidotic Polyneuropathy With Transthyretin p.Ala117Ser Mutation in Mainland China

Haishan Jiang, L. Meng, Zhaoyong Zhang, 2021 .

Investigating Derivatives of Tanshinone IIA Sulfonate Sodium and Chloroxine for Their Inhibition Activities against the SARS-CoV-2 Papain-like Protease

J. Zhan, Jincun Zhao, Yanqun Wang, 2022, ACS omega.

Narrative review of the novel coronavirus SARS-CoV-2: update on genomic characteristics, transmissions and animal model

Jincun Zhao, Jingxian Zhao, Zi-feng Yang, 2020, Journal of thoracic disease.

Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment

Rongchang Chen, Jincun Zhao, Jingxian Zhao, 2020, Cell.

Population Bottlenecks and Intra-host Evolution During Human-to-Human Transmission of SARS-CoV-2

Junhua Li, Huanzi Zhong, Wenwei Zhang, 2020, bioRxiv.

Mapping and role of T cell response in SARS-CoV-2–infected mice

Jincun Zhao, Jingxian Zhao, Yanqun Wang, 2021, The Journal of experimental medicine.

Kinetics of viral load and antibody response in relation to COVID-19 severity.

Liyan Wen, Lu Zhang, Jingxian Zhao, 2020, The Journal of clinical investigation.

Increased Pathogenicity and Virulence of Middle East Respiratory Syndrome Coronavirus Clade B In Vitro and In Vivo

Rongchang Chen, Jincun Zhao, Jingxian Zhao, 2020, Journal of Virology.

Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2

Jincun Zhao, Jingxian Zhao, M. Peiris, 2023, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients

Junhua Li, K. Kristiansen, Huanzi Zhong, 2021, Cell Discovery.

Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients

Junhua Li, Huanming Yang, Jian Wang, 2021, Cell discovery.

Characterization of Microbial Co-infections in the Respiratory Tract of hospitalized COVID-19 patients

Junhua Li, Huanming Yang, Jian Wang, 2020, medRxiv.

Broadly Effective ACE2 Decoy Proteins Protect Mice from Lethal SARS-CoV-2 Infection

Jincun Zhao, Yanqun Wang, Yandong Yin, 2023, bioRxiv.

Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery

H. Tun, Jincun Zhao, Jingxian Zhao, 2021, Signal Transduction and Targeted Therapy.

Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients

Junhua Li, Huanzi Zhong, Weijun Chen, 2021, Genome medicine.

Intra-host Variation and Evolutionary Dynamics of SARS-CoV-2 Population in COVID-19 Patients

Junhua Li, Huanming Yang, Jian Wang, 2020, bioRxiv.

Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo

Jincun Zhao, Jingxian Zhao, Yanqun Wang, 2021, Cell discovery.

Correction: Mapping and role of T cell response in SARS-CoV-2–infected mice

Jincun Zhao, Jingxian Zhao, Yanqun Wang, 2021, The Journal of experimental medicine.

Retraction “Advances in drug therapy for mitochondrial diseases”

Haishan Jiang, Zhaoyong Zhang, Lufei Zhang, 2020, Annals of translational medicine.

Plasma cell-free DNA promise monitoring and tissue injury assessment of COVID-19

Huanming Yang, Xin Jin, Jincun Zhao, 2023, Molecular Genetics and Genomics.

Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018

Fuchun Zhang, Jincun Zhao, Jingxian Zhao, 2020, Emerging microbes & infections.

Genetic and pathogenicity diversity of dengue virus type 2 strains circulating in Guangdong, China

Jian Wang, Ling-Zhai Zhao, Fuchun Zhang, 2021, Biosafety and Health.

Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants

Jincun Zhao, Xinquan Wang, Renli Zhang, 2023, Nature communications.

Organo-Se BTSAs-enabled performance: From racemic and asymmetric synthesis to click chemistry application

Wei Zhang, Wei Peng, Zhi Zhou, 2023, Chem.

A potent neutralizing nanobody targeting a unique epitope on the receptor-binding domain of SARS-CoV-2 spike protein.

Yanqun Wang, Haihai Jiang, Zhaoyong Zhang, 2023, Virology.

Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain.

Jingxian Zhao, Xiangxi Wang, Yanqun Wang, 2024, Cell reports.

An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike.

Yanqun Wang, Qiuluan Chen, Xuefeng Niu, 2024, Cell reports.

A potent and broad‐spectrum neutralizing nanobody for SARS‐CoV‐2 viruses, including all major Omicron strains

Jincun Zhao, Yanqun Wang, Zhaoyong Zhang, 2023, MedComm.

A bispecific antibody exhibits broad neutralization against SARS-CoV-2 Omicron variants XBB.1.16, BQ.1.1 and sarbecoviruses

Yanqun Wang, Zhaoyong Zhang, Aihua Hao, 2024, Nature communications.

SARS-CoV-2 Damages Cardiomyocytes Mitochondria and Implicates Long COVID-associated Cardiovascular Manifestations

Xiaohua Wan, W. Che, Yanqun Wang, 2024, medRxiv.